Lucida Medical’s mission is to use artificial Intelligence (AI) to find cancer earlier. Our first product is called Pi™ (Prostate Intelligence), which detects prostate cancer from multi-parametric MRI scans. Pi™ is a CE-marked medical device to support the analysis of MRI scans of prostate cancer. It is not currently for sale or use in the USA.
Lucida Medical is a spin off from Cambridge University, and is based in Cambridge, England. It was founded in 2018 by Dr Antony Rix, who has 25 years’ experience in AI and Machine Learning, and Professor Evis Sala, a globally recognised Radiologist in prostate and gynaecological imaging. They are supported by a team of AI engineers and scientists, as well as experts in clinical research, regulatory compliance, and experienced prostate Radiologists.
